ACH-000029

N/A

Report date: 2025/03/27 20:00:06
NME

Base Information

Drug NameACH-000029
Drug Alias NameACH000029
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonistsSerotonin 1a (5-HT1a) receptor agonistsSerotonin 2a (5-HT2a) receptor antagonists +[5] 
TargetsAdrenergic receptors alpha-1Alpha-1a adrenergic receptorSerotonin 2a (5-HT2a) receptor +[5] 
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAche Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOtsuka Pharmaceutical Development & Commercialization Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A